Peter Sullivan is a health care policy reporter for Axios, with a focus on national issues in the United States. He has previously worked for The Hill and has appeared on various news outlets discussing health care topics. Peter's reporting covers a wide range of health care issues, including drug pricing, access to treatment, and legislative developments.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Peter Sullivan's coverage primarily focuses on national US government announcements, legal policy regulation, and healthcare-related themes. His articles often cover legislative actions related to healthcare policies, making him likely interested in pitches that provide insights into the impact of new legislation or regulatory changes on the healthcare industry.
Given his focus on government announcements and health policy, Peter may be receptive to expert commentary from individuals with direct experience in navigating legislative processes or implementing healthcare policies. Additionally, he might be interested in analysis from experts who can contextualize how specific regulations or bills could affect different stakeholders within the healthcare sector.
Since Peter's geographic focus is national (United States), relevant sources should have expertise in US healthcare legislation and a deep understanding of its potential implications at both federal and state levels.
This information evolves through artificial intelligence and human feedback. Improve this profile .
A short-term CR into early next year is potentially a bad sign for a major health package.
The unorthodox nomination of the vaccine critic hasn't to date revealed any cracks in the GOP ranks.
Key Republican senators
President-elect Donald Trump's selection of Mehmet Oz, or Dr. Oz, to lead CMS adds to the uncertainty over the future of Medicare, Medicaid and the Affordable Care Act.
President-elect Trump's selection of Mehmet Oz, or Dr. Oz, to lead CMS adds to the uncertainty over the future of Medicare, Medicaid and the Affordable Care Act, Victoria and Peter report.
President-elect
Changes could significantly reshape the safety net program that covers more than 70 million people, saving money but also potentially leading to coverage losses.
Congressional Republicans
A prospective
The FDA's
(833) 317-6278 
